Posted Aug. 25, 2014 at 5:19 a.m.

Premium Lock Roche to buy biotech firm InterMune for $8.3 billion

Published: 2014-08-25 05:19:39
Updated: 2014-08-25 05:19:39

Switzerland Roche InterMune Swiss pharmaceutical company Roche says it will buy InterMune, Inc., a California-based developer of treatments for lung diseases, in a deal worth $8.3 billion. Roche said Sunday the companies have reached an agreement under which Roche will acquire InterMune in an all-cash transaction. (AP Photo/Keystone/Urs Flueeler, File)

Swiss pharmaceutical company Roche said Sunday it has reached an $8.3 billion deal to buy InterMune Inc., a California-based developer of treatments for lung diseases....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 by The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll